Brand Name - Evista®

Generic Name - raloxifene hydrochloride

FDA Drug Classification - Selective estrogen receptor modulator

Action - Reduces reabsorption of bone and bone "turnover" which leads to bone loss known as osteoporosis

Adverse Effects -

• Hot flashes
• Weight gain
• Edema or swelling

Precautions - Should not be used by:

• Use with caution in women with circulatory disorders as it may increase risk of blood clots
• Use with caution in women experiencing abnormal uterine bleeding.

Interactions -

• Should not be used with Cholestyramine as it affects it's absorption.
• Monitor protrombin time if given to a patient on warfarin (coumadin)